Sentences with phrase «vaccine products marketed»
• Pharmaceutical: Human pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.
http://dailytradealert.com/ Not exact matches
The Animal Health business discovers, develops, manufactures, and markets animal health products including antibiotics, anti-inflammatory, vaccines, fertility disorder treatments, and parasiticides for cattle, swine, horses, poultry, dogs, cats, and fish.
China now has numerous life science companies that serve its domestic market, providing greater access to medical products and facilitating the development of the country's first WHO - prequalified vaccine.
Jones, who earned a PhD while working in Pfeifer's lab, has formed a company, Abcombi Biosciences, to bring the vaccine and other pharmaceutical products to market.
Building on a 60 - year history as the animal health business of Pfizer Inc., Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Rising pet adoption, expansion of key vaccine players in the APAC region, and the wide range of new product launches and investments in manufacturing facilities, especially in India, China, and Thailand are driving market growth in this region.
About Ceva Santé Animale S.A: Ceva Santé Animale is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
About Ceva Sante Animale: Ceva Sante Animale is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
Ceva's parent company is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
Building on a 60 - year history as the animal health arm of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures, and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests.
About Ceva Santé Animale: Ceva's parent company is a global veterinary health company focused on the research, development, production and marketing of pharmaceutical products and vaccines for pets, livestock, swine and poultry.
Animal Safety Neogen's Animal Safety Division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market.
Several years ago, an «all - killed» combination vaccine for dogs was marketed, but some users encountered minor problems with discoloration and local reactions at the injection site, and the product was withdrawn.
Building on a 60 - year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services with a focus on both farm and companion animals.
Under the terms of the agreement, Elanco will acquire European rights to a portfolio of products previously marketed by Pfizer Animal Health and Fort Dodge Animal Health, including vaccines, parasiticides and feed additives, that are used in both food production animal and companion animal segments, as well as a Fort Dodge biologicals manufacturing facility in Sligo, Ireland.
Boehringer Ingelheim Vetmedica, Inc., (BIVI) is the fifth largest animal health company in the U.S. and produces innovative vaccine and pharmaceutical products for the prevention and treatment of diseases in the swine, cattle, equine and companion animal markets.
However, more than three years after publication of the APVMA's Position Statement, core vaccine products with an annual revaccination «recommendation» remain on the market, e.g. Virbac's Canigen DHA2P (11) and Boehringer Ingelheim's Protech C3 (12).
Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services.
As popular drug patents expire and a flood of generic medicines are expected to flood the market, the large firms are looking for better ways to earn revenue, such as expanding globally by pushing into emerging markets such as Brazil and China, or exploring more research and development of biopharma products (biological medicines, based on living tissues such as vaccines).